Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells

PURPOSE: mTORC1 and mTORC2 inhibition by Ku-0063794 could confer profound anticancer effects against cancer cells because it eliminates feedback activation of Akt. Herein, we aimed to determine anticancer effects of docetaxel and Ku-0063794, individually or in combination, against breast cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Ye-Won, Kim, Ok-Hee, Shin, Jin Sun, Hong, Ha Eun, Kim, Cho Hee, Kim, Say-June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756118/
https://www.ncbi.nlm.nih.gov/pubmed/33831291
http://dx.doi.org/10.4143/crt.2020.1063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756118/
https://www.ncbi.nlm.nih.gov/pubmed/33831291
http://dx.doi.org/10.4143/crt.2020.1063

Ejemplares similares